Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of -128297.25% is 553% below its 5-year average of -19643.17%, near the low end of its 5-year range (-128297.25%–-375.74%).
347.18% below its 12-month average of -28690.12%.
Reported quarterly EBITDA margin; no daily interpolation. Q1 FY2025 (2025-03-31): -37199.21%.
EBITDA MARGIN
-128297.25%
EBITDA MARGIN AVG TTM
-28690.12%
EBITDA MARGIN AVG 3Y
-24291.28%
EBITDA MARGIN AVG 5Y
-19643.17%
EBITDA MARGIN AVG 10Y
-9754.12%
EBITDA MARGIN AVG 15Y
-4382.93%
EBITDA MARGIN AVG 20Y
-515.75%
CURRENT VS TTM AVG
-347.18%
CURRENT VS 3Y AVG
-428.16%
CURRENT VS 5Y AVG
-553.14%
CURRENT VS 10Y AVG
-1215.31%
CURRENT VS 15Y AVG
-2827.20%
CURRENT VS 20Y AVG
-24775.71%
Inovio Pharmaceuticals, Inc.
Market Cap
$79.46M
EBITDA Margin
-128297.25%
TTM Avg
-28690.12%
3Y Avg
-24291.28%
5Y Avg
-19643.17%
Market Cap
$79.82M
EBITDA Margin
-43906.17%
TTM Avg
-45201.13%
3Y Avg
-29968.45%
5Y Avg
-38423.13%
Market Cap
$78.57M
EBITDA Margin
-145368.18%
TTM Avg
-145368.18%
3Y Avg
-145368.18%
5Y Avg
-145368.18%
Market Cap
$78.14M
EBITDA Margin
-58.13%
TTM Avg
-62.55%
3Y Avg
-79.72%
5Y Avg
-85.39%
Market Cap
$82.07M
EBITDA Margin
-398.90%
TTM Avg
-349.10%
3Y Avg
-274.94%
5Y Avg
-268.47%
Market Cap
$82.45M
EBITDA Margin
-3237.56%
TTM Avg
-3237.56%
3Y Avg
-2112.78%
5Y Avg
-1492.65%
Market Cap
$82.82M
EBITDA Margin
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$76.00M
EBITDA Margin
-52.21%
TTM Avg
-73.45%
3Y Avg
-101.69%
5Y Avg
-126.11%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Inovio Pharmaceuticals, Inc. (INO) | $79.46M | -128297.25% | -28690.12% | -24291.28% | -19643.17% |
| Sera Prognostics, Inc. (SERA)vs › | $79.82M | -43906.17% | -45201.13% | -29968.45% | -38423.13% |
| Neonc Technologies Holdings, Inc. (NTHI)vs › | $78.57M | -145368.18% | -145368.18% | -145368.18% | -145368.18% |
| Pulmonx Corporation (LUNG)vs › | $78.14M | -58.13% | -62.55% | -79.72% | -85.39% |
| Nutriband Inc. (NTRB)vs › | $82.07M | -398.90% | -349.10% | -274.94% | -268.47% |
| MediciNova, Inc. (MNOV)vs › | $82.45M | -3237.56% | -3237.56% | -2112.78% | -1492.65% |
| LENSAR Inc (LNSR)vs › | $82.59M | -34.36% | -23.48% | -28.76% | -37.09% |
| Acrivon Therapeutics, Inc. Common Stock (ACRV)vs › | $82.82M | N/A | N/A | N/A | N/A |
| Outset Medical, Inc. (OM)vs › | $76.00M | -52.21% | -73.45% | -101.69% | -126.11% |
| SkinHealth Systems Inc. (SKIN)vs › | $75.91M | 1.51% | -4.98% | -8.74% | -7.62% |
Gross Margin
100.0%
EBITDA Margin
-128297.3%
Operating Margin
-132871.3%
Net Margin
-130000.0%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2025-03-31 | -37199.21% |
| 2024-12-31 | -16747.64% |
| 2024-06-30 | -32123.51% |
| 2023-12-31 | -26515.58% |
| 2023-09-30 | -8886.75% |
| 2023-06-30 | -15885.97% |
| 2023-03-31 | -37235.89% |
| 2022-12-31 | -43795.15% |
| 2022-09-30 | -375.74% |
| 2022-06-30 | -13096.37% |
| 2022-03-31 | -35342.26% |
| 2021-12-31 | -12409.40% |
| 2021-09-30 | -20157.12% |
| 2021-06-30 | -30085.82% |
| 2021-03-31 | -13871.18% |
| 2020-12-31 | -491.80% |
| 2020-09-30 | -15021.39% |
| 2020-06-30 | -12170.22% |
| 2020-03-31 | -1809.30% |
| 2019-12-31 | -10179.60% |
| 2019-09-30 | -2630.40% |
| 2019-06-30 | -19902.13% |
| 2019-03-31 | -966.02% |
| 2018-12-31 | -1128.96% |
| 2018-09-30 | -1271.90% |
| 2018-06-30 | -16.15% |
| 2018-03-31 | -2055.66% |
| 2017-12-31 | -255.07% |
| 2017-09-30 | -1059.62% |
| 2017-06-30 | -42.78% |
| 2017-03-31 | -202.44% |
| 2016-12-31 | -252.98% |
| 2016-09-30 | -154.04% |
| 2016-06-30 | -281.12% |
| 2016-03-31 | -183.14% |
| 2015-12-31 | -235.86% |
| 2015-09-30 | 17.48% |
| 2015-06-30 | -277.37% |
| 2015-03-31 | -153.49% |
| 2014-12-31 | -430.73% |
| 2014-09-30 | -429.91% |
| 2014-06-30 | -257.43% |
| 2014-03-31 | -409.08% |
| 2013-12-31 | -423.17% |
| 2013-09-30 | 13.16% |
| 2013-06-30 | -660.10% |
| 2013-03-31 | -422.36% |
| 2012-12-31 | -504.69% |
| 2012-09-30 | -677.63% |
| 2012-06-30 | -1442.57% |
| 2012-03-31 | -217.89% |
| 2011-12-31 | -323.20% |
| 2011-09-30 | -221.22% |
| 2011-06-30 | -191.47% |
| 2011-03-31 | -133.06% |
| 2010-12-31 | -201.45% |
| 2010-09-30 | -315.49% |
| 2010-06-30 | -391.72% |
| 2010-03-31 | -282.86% |
| 2009-12-31 | -124.55% |
| 2009-09-30 | -83.47% |
| 2009-06-30 | -106.36% |
| 2009-03-31 | -902.09% |
| 2008-12-31 | -986.90% |
| 2008-09-30 | -543.03% |
| 2008-06-30 | -582.69% |
| 2008-03-31 | -475.79% |
| 2007-12-31 | -46.88% |
| 2007-09-30 | -984.73% |
| 2007-06-30 | -912.61% |
| 2007-03-31 | -808.30% |
| 2006-12-31 | -237.29% |
| 2006-09-30 | -563.46% |
| 2006-06-30 | -451.31% |
| 2006-03-31 | -367.45% |
| 2005-12-31 | -350.16% |
| 2005-09-30 | -387.10% |
| 2005-06-30 | -66.74% |
| 2005-03-31 | -730.79% |
| 2004-12-31 | -687.94% |
| 2004-09-30 | -746.05% |
| 2004-06-30 | -2329.83% |
| 2004-03-31 | -2136.87% |
| 2003-12-31 | -4343.71% |
| 2003-09-30 | -6957.24% |
| 2003-06-30 | -13971.52% |
| 2003-03-31 | -14383.58% |
| 2002-12-31 | -1702.32% |
| 2002-09-30 | -1925.93% |
